These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
322 related articles for article (PubMed ID: 26819308)
21. Neutralization resistance of hepatitis C virus can be overcome by recombinant human monoclonal antibodies. Pedersen J; Carlsen TH; Prentoe J; Ramirez S; Jensen TB; Forns X; Alter H; Foung SK; Law M; Gottwein J; Weis N; Bukh J Hepatology; 2013 Nov; 58(5):1587-97. PubMed ID: 23729237 [TBL] [Abstract][Full Text] [Related]
22. Characterization of linear epitope specificity of antibodies potentially contributing to spontaneous clearance of hepatitis C virus. Ahsan A; Dar S; Hassan F; Ghafoor F; Yousuf MH; Shahzad-Ul-Hussan S PLoS One; 2021; 16(8):e0256816. PubMed ID: 34449828 [TBL] [Abstract][Full Text] [Related]
23. Glycan shifting on hepatitis C virus (HCV) E2 glycoprotein is a mechanism for escape from broadly neutralizing antibodies. Pantua H; Diao J; Ultsch M; Hazen M; Mathieu M; McCutcheon K; Takeda K; Date S; Cheung TK; Phung Q; Hass P; Arnott D; Hongo JA; Matthews DJ; Brown A; Patel AH; Kelley RF; Eigenbrot C; Kapadia SB J Mol Biol; 2013 Jun; 425(11):1899-1914. PubMed ID: 23458406 [TBL] [Abstract][Full Text] [Related]
24. Broadly Neutralizing Antibody Mediated Clearance of Human Hepatitis C Virus Infection. Kinchen VJ; Zahid MN; Flyak AI; Soliman MG; Learn GH; Wang S; Davidson E; Doranz BJ; Ray SC; Cox AL; Crowe JE; Bjorkman PJ; Shaw GM; Bailey JR Cell Host Microbe; 2018 Nov; 24(5):717-730.e5. PubMed ID: 30439341 [TBL] [Abstract][Full Text] [Related]
25. Altered Glycosylation Patterns Increase Immunogenicity of a Subunit Hepatitis C Virus Vaccine, Inducing Neutralizing Antibodies Which Confer Protection in Mice. Li D; von Schaewen M; Wang X; Tao W; Zhang Y; Li L; Heller B; Hrebikova G; Deng Q; Ploss A; Zhong J; Huang Z J Virol; 2016 Dec; 90(23):10486-10498. PubMed ID: 27630242 [TBL] [Abstract][Full Text] [Related]
26. Junctional and somatic hypermutation-induced CX Yi C; Xia J; He L; Ling Z; Wang X; Yan Y; Wang J; Zhao X; Fan W; Sun X; Zhang R; Ye S; Zhang R; Xu Y; Ma L; Zhang Y; Zhou H; Huang Z; Niu J; Long G; Lu J; Zhong J; Sun B Cell Mol Immunol; 2021 Mar; 18(3):675-685. PubMed ID: 32235917 [TBL] [Abstract][Full Text] [Related]
27. Antibody Response to Hypervariable Region 1 Interferes with Broadly Neutralizing Antibodies to Hepatitis C Virus. Keck ZY; Girard-Blanc C; Wang W; Lau P; Zuiani A; Rey FA; Krey T; Diamond MS; Foung SK J Virol; 2016 Jan; 90(6):3112-22. PubMed ID: 26739044 [TBL] [Abstract][Full Text] [Related]
28. Genetic and structural insights into broad neutralization of hepatitis C virus by human V Tzarum N; Giang E; Kong L; He L; Prentoe J; Augestad E; Hua Y; Castillo S; Lauer GM; Bukh J; Zhu J; Wilson IA; Law M Sci Adv; 2019 Jan; 5(1):eaav1882. PubMed ID: 30613781 [TBL] [Abstract][Full Text] [Related]
32. Additional glycosylation within a specific hypervariable region of subtype 3a of hepatitis C virus protects against virus neutralization. Anjum S; Wahid A; Afzal MS; Albecka A; Alsaleh K; Ahmad T; Baumert TF; Wychowski C; Qadri I; Penin F; Dubuisson J J Infect Dis; 2013 Dec; 208(11):1888-97. PubMed ID: 23908491 [TBL] [Abstract][Full Text] [Related]
33. Expression, purification and immunogenic characterization of hepatitis C virus recombinant E1E2 protein expressed by Pichia pastoris yeast. Cai W; Su L; Liao Q; Ye L; Wu Y; Wu Z; She Y Antiviral Res; 2010 Oct; 88(1):80-5. PubMed ID: 20691736 [TBL] [Abstract][Full Text] [Related]
34. The role of neutralizing antibodies in hepatitis C virus infection. Edwards VC; Tarr AW; Urbanowicz RA; Ball JK J Gen Virol; 2012 Jan; 93(Pt 1):1-19. PubMed ID: 22049091 [TBL] [Abstract][Full Text] [Related]
35. Neutralizing activity and safety of human monoclonal antibodies against hepatitis C virus. Abdel Malak CA; Abelhafez TH; Tabll AA; Mashaly MM; El Shenawy R; El-Abd YS; Shaker MH; El-Awady MK Hum Antibodies; 2017; 26(3):127-134. PubMed ID: 29036810 [TBL] [Abstract][Full Text] [Related]
36. Hepatitis C virus Broadly Neutralizing Monoclonal Antibodies Isolated 25 Years after Spontaneous Clearance. Merat SJ; Molenkamp R; Wagner K; Koekkoek SM; van de Berg D; Yasuda E; Böhne M; Claassen YB; Grady BP; Prins M; Bakker AQ; de Jong MD; Spits H; Schinkel J; Beaumont T PLoS One; 2016; 11(10):e0165047. PubMed ID: 27776169 [TBL] [Abstract][Full Text] [Related]
37. Establishment of human clones producing neutralizing human monoclonal antibodies to the envelope E1/E2 protein of hepatitis C virus by EBV immortalization of immune CD22⁺ B cells. Tabll A; El Abd Y; El Din NG; El Shenawy R; Abdelhafez TH; El Awady M; El-Mohamady H; Viazov S Hum Antibodies; 2013; 22(3-4):55-65. PubMed ID: 24961863 [TBL] [Abstract][Full Text] [Related]
38. Hepatitis C Virus Epitope Immunodominance and B Cell Repertoire Diversity. Brasher NA; Adhikari A; Lloyd AR; Tedla N; Bull RA Viruses; 2021 May; 13(6):. PubMed ID: 34070572 [TBL] [Abstract][Full Text] [Related]
40. Immunization With a Subunit Hepatitis C Virus Vaccine Elicits Pan-Genotypic Neutralizing Antibodies and Intrahepatic T-Cell Responses in Nonhuman Primates. Li D; Wang X; von Schaewen M; Tao W; Zhang Y; Heller B; Hrebikova G; Deng Q; Sun Q; Ploss A; Zhong J; Huang Z J Infect Dis; 2017 Jun; 215(12):1824-1831. PubMed ID: 28398489 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]